Benitec Biopharma Inc. is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines with headquarters in Hayward, California. The proprietary platform, called DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitate sustained silencing of disease-causing genes following a single administration. The Company is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy (OPMD).
Company Profile
Industry Classifications
Sector
Healthcare
Industry
Biotechnology
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
Contact Information
Investor Relations
LifeSci Advisors
Irina Koffler
Managing Director
T: 646-970-4681
ikoffler@lifesciadvisors.com
Transfer Agent
Computershare Investor Services
P.O. Box 505005
Louisville, KY 40233-5005
T: 781-575-3100
Company Contact
Benitec Biopharma Inc.
3940 Trust Way
Hayward, CA 94545
T: +1 (510) 780-0634